tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Evercore disagrees with Street reaction on Alkermes
PremiumThe FlyEvercore disagrees with Street reaction on Alkermes
1M ago
Alkermes initiated with a Buy at Truist
Premium
The Fly
Alkermes initiated with a Buy at Truist
1M ago
Takeda presents interim data from Phase 1b study of mezagitamab
Premium
The Fly
Takeda presents interim data from Phase 1b study of mezagitamab
1M ago
Innovent Biologics announces global strategic partnership with Takeda
PremiumThe FlyInnovent Biologics announces global strategic partnership with Takeda
2M ago
Keros Therapeutics announces share repurchase program
Premium
The Fly
Keros Therapeutics announces share repurchase program
2M ago
Sector Spotlight: UnitedHealth shareholder proposes split of CEO, chair role
Premium
The Fly
Sector Spotlight: UnitedHealth shareholder proposes split of CEO, chair role
2M ago
Takeda, Vela Transport announce medicine shipping partnership
PremiumThe FlyTakeda, Vela Transport announce medicine shipping partnership
3M ago
Protagonist Therapeutics initiated with an Outperform at Leerink
Premium
The Fly
Protagonist Therapeutics initiated with an Outperform at Leerink
3M ago
Alkermes price target lowered to $43 from $45 at Needham
Premium
The Fly
Alkermes price target lowered to $43 from $45 at Needham
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100